Loading…

The impact of gender on clinical manifestations of primary antiphospholipid syndrome

The objective of the study was to determine the clinical differences at diagnosis and during follow-up between male and female patients with primary antiphospholipid syndrome (PAPS). We analysed 68 patients, 30 males and 38 females diagnosed and followed between 1990 and 2003. Patients with antiphos...

Full description

Saved in:
Bibliographic Details
Published in:Lupus 2005-08, Vol.14 (8), p.607-612
Main Authors: Jara, L J, Medina, G, Vera-Lastra, O, Barile, L
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33
cites cdi_FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33
container_end_page 612
container_issue 8
container_start_page 607
container_title Lupus
container_volume 14
creator Jara, L J
Medina, G
Vera-Lastra, O
Barile, L
description The objective of the study was to determine the clinical differences at diagnosis and during follow-up between male and female patients with primary antiphospholipid syndrome (PAPS). We analysed 68 patients, 30 males and 38 females diagnosed and followed between 1990 and 2003. Patients with antiphospholipid syndrome associated with systemic lupus erythematosus at onset and during follow-up were excluded. The mean age at diagnosis was 31.4 ± 11 years in males and 35.7 ± 11 years in females (NS). The follow-up after diagnosis was 8.7 ± 3.1 years in males and 9.2 ± 2.9 years in females (NS). We did not find significant differences between the two groups with respect to venous and arterial thrombosis. However, in female patients, stroke was more prevalent than in male patients (12/38 versus 3/30, P = 0.03). In contrast, we found a significant prevalence of severe gastrointestinal complications in male compared to female patients (7/30 versus 1/38, P = 0.009). One male patient died due to catastrophic antiphospholipid syndrome. This study suggests that clinical course in patients with PAPS may be different with significant prevalence of central nervous system involvement in females and gastrointestinal involvement in males. Factors such as accelerated atherosclerosis, hormones, related to gender could be the explanation of these findings.
doi_str_mv 10.1191/0961203305lu2176oa
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68610129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1191_0961203305lu2176oa</sage_id><sourcerecordid>896410041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33</originalsourceid><addsrcrecordid>eNp9kD9PwzAQxS0EoqXwBRhQxMAW6rMTuxkR4p9UiaXMkZOcW1eJHexk6LcnUSNVAonhdMP97t27R8gt0EeADJY0E8Ao5zStewZSOHVG5pBIGQ8Tdk7mIxCPxIxchbCnlHLIxCWZgQCZZpzNyWazw8g0rSq7yOloi7ZCHzkblbWxplR11ChrNIZOdcbZMEKtN43yh0jZzrQ7F4aqTWuqKBxs5V2D1-RCqzrgzdQX5Ov1ZfP8Hq8_3z6en9ZxmfCkixUHhBRRFymgpkrKgmIlM5lonjJdUC4S1ForxpFXAjkrypWUqyoFLQE5X5CHo27r3Xc_eMwbE0qsa2XR9SEXKwEUWDaA97_Aveu9HbzljDEBfMWSAWJHqPQuBI86nx7NgeZj4PnfwIelu0m5LxqsTitTwgOwPAJBbfF09h_JH9PAi7U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222613824</pqid></control><display><type>article</type><title>The impact of gender on clinical manifestations of primary antiphospholipid syndrome</title><source>Sage Journals Online</source><creator>Jara, L J ; Medina, G ; Vera-Lastra, O ; Barile, L</creator><creatorcontrib>Jara, L J ; Medina, G ; Vera-Lastra, O ; Barile, L</creatorcontrib><description>The objective of the study was to determine the clinical differences at diagnosis and during follow-up between male and female patients with primary antiphospholipid syndrome (PAPS). We analysed 68 patients, 30 males and 38 females diagnosed and followed between 1990 and 2003. Patients with antiphospholipid syndrome associated with systemic lupus erythematosus at onset and during follow-up were excluded. The mean age at diagnosis was 31.4 ± 11 years in males and 35.7 ± 11 years in females (NS). The follow-up after diagnosis was 8.7 ± 3.1 years in males and 9.2 ± 2.9 years in females (NS). We did not find significant differences between the two groups with respect to venous and arterial thrombosis. However, in female patients, stroke was more prevalent than in male patients (12/38 versus 3/30, P = 0.03). In contrast, we found a significant prevalence of severe gastrointestinal complications in male compared to female patients (7/30 versus 1/38, P = 0.009). One male patient died due to catastrophic antiphospholipid syndrome. This study suggests that clinical course in patients with PAPS may be different with significant prevalence of central nervous system involvement in females and gastrointestinal involvement in males. Factors such as accelerated atherosclerosis, hormones, related to gender could be the explanation of these findings.</description><identifier>ISSN: 0961-2033</identifier><identifier>EISSN: 1477-0962</identifier><identifier>DOI: 10.1191/0961203305lu2176oa</identifier><identifier>PMID: 16175932</identifier><language>eng</language><publisher>Thousand Oaks, CA: SAGE Publications</publisher><subject>Adult ; Antibodies, Anticardiolipin - blood ; Anticoagulants ; Antiphospholipid Syndrome - blood ; Antiphospholipid Syndrome - complications ; Cardiovascular Diseases - etiology ; Disease ; Epidemiology ; Female ; Females ; Follow-Up Studies ; Gender ; Hospitals ; Humans ; Kidney Diseases - etiology ; Lupus ; Male ; Males ; Middle Aged ; Retrospective Studies ; Sex Factors ; Skin Diseases - etiology ; Thrombocytopenia ; Thrombocytopenia - etiology ; Thrombosis ; Womens health</subject><ispartof>Lupus, 2005-08, Vol.14 (8), p.607-612</ispartof><rights>2005 Arnold</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33</citedby><cites>FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16175932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jara, L J</creatorcontrib><creatorcontrib>Medina, G</creatorcontrib><creatorcontrib>Vera-Lastra, O</creatorcontrib><creatorcontrib>Barile, L</creatorcontrib><title>The impact of gender on clinical manifestations of primary antiphospholipid syndrome</title><title>Lupus</title><addtitle>Lupus</addtitle><description>The objective of the study was to determine the clinical differences at diagnosis and during follow-up between male and female patients with primary antiphospholipid syndrome (PAPS). We analysed 68 patients, 30 males and 38 females diagnosed and followed between 1990 and 2003. Patients with antiphospholipid syndrome associated with systemic lupus erythematosus at onset and during follow-up were excluded. The mean age at diagnosis was 31.4 ± 11 years in males and 35.7 ± 11 years in females (NS). The follow-up after diagnosis was 8.7 ± 3.1 years in males and 9.2 ± 2.9 years in females (NS). We did not find significant differences between the two groups with respect to venous and arterial thrombosis. However, in female patients, stroke was more prevalent than in male patients (12/38 versus 3/30, P = 0.03). In contrast, we found a significant prevalence of severe gastrointestinal complications in male compared to female patients (7/30 versus 1/38, P = 0.009). One male patient died due to catastrophic antiphospholipid syndrome. This study suggests that clinical course in patients with PAPS may be different with significant prevalence of central nervous system involvement in females and gastrointestinal involvement in males. Factors such as accelerated atherosclerosis, hormones, related to gender could be the explanation of these findings.</description><subject>Adult</subject><subject>Antibodies, Anticardiolipin - blood</subject><subject>Anticoagulants</subject><subject>Antiphospholipid Syndrome - blood</subject><subject>Antiphospholipid Syndrome - complications</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Disease</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Females</subject><subject>Follow-Up Studies</subject><subject>Gender</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Kidney Diseases - etiology</subject><subject>Lupus</subject><subject>Male</subject><subject>Males</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Sex Factors</subject><subject>Skin Diseases - etiology</subject><subject>Thrombocytopenia</subject><subject>Thrombocytopenia - etiology</subject><subject>Thrombosis</subject><subject>Womens health</subject><issn>0961-2033</issn><issn>1477-0962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kD9PwzAQxS0EoqXwBRhQxMAW6rMTuxkR4p9UiaXMkZOcW1eJHexk6LcnUSNVAonhdMP97t27R8gt0EeADJY0E8Ao5zStewZSOHVG5pBIGQ8Tdk7mIxCPxIxchbCnlHLIxCWZgQCZZpzNyWazw8g0rSq7yOloi7ZCHzkblbWxplR11ChrNIZOdcbZMEKtN43yh0jZzrQ7F4aqTWuqKBxs5V2D1-RCqzrgzdQX5Ov1ZfP8Hq8_3z6en9ZxmfCkixUHhBRRFymgpkrKgmIlM5lonjJdUC4S1ForxpFXAjkrypWUqyoFLQE5X5CHo27r3Xc_eMwbE0qsa2XR9SEXKwEUWDaA97_Aveu9HbzljDEBfMWSAWJHqPQuBI86nx7NgeZj4PnfwIelu0m5LxqsTitTwgOwPAJBbfF09h_JH9PAi7U</recordid><startdate>200508</startdate><enddate>200508</enddate><creator>Jara, L J</creator><creator>Medina, G</creator><creator>Vera-Lastra, O</creator><creator>Barile, L</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>200508</creationdate><title>The impact of gender on clinical manifestations of primary antiphospholipid syndrome</title><author>Jara, L J ; Medina, G ; Vera-Lastra, O ; Barile, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Antibodies, Anticardiolipin - blood</topic><topic>Anticoagulants</topic><topic>Antiphospholipid Syndrome - blood</topic><topic>Antiphospholipid Syndrome - complications</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Disease</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Females</topic><topic>Follow-Up Studies</topic><topic>Gender</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Kidney Diseases - etiology</topic><topic>Lupus</topic><topic>Male</topic><topic>Males</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Sex Factors</topic><topic>Skin Diseases - etiology</topic><topic>Thrombocytopenia</topic><topic>Thrombocytopenia - etiology</topic><topic>Thrombosis</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jara, L J</creatorcontrib><creatorcontrib>Medina, G</creatorcontrib><creatorcontrib>Vera-Lastra, O</creatorcontrib><creatorcontrib>Barile, L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Lupus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jara, L J</au><au>Medina, G</au><au>Vera-Lastra, O</au><au>Barile, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of gender on clinical manifestations of primary antiphospholipid syndrome</atitle><jtitle>Lupus</jtitle><addtitle>Lupus</addtitle><date>2005-08</date><risdate>2005</risdate><volume>14</volume><issue>8</issue><spage>607</spage><epage>612</epage><pages>607-612</pages><issn>0961-2033</issn><eissn>1477-0962</eissn><abstract>The objective of the study was to determine the clinical differences at diagnosis and during follow-up between male and female patients with primary antiphospholipid syndrome (PAPS). We analysed 68 patients, 30 males and 38 females diagnosed and followed between 1990 and 2003. Patients with antiphospholipid syndrome associated with systemic lupus erythematosus at onset and during follow-up were excluded. The mean age at diagnosis was 31.4 ± 11 years in males and 35.7 ± 11 years in females (NS). The follow-up after diagnosis was 8.7 ± 3.1 years in males and 9.2 ± 2.9 years in females (NS). We did not find significant differences between the two groups with respect to venous and arterial thrombosis. However, in female patients, stroke was more prevalent than in male patients (12/38 versus 3/30, P = 0.03). In contrast, we found a significant prevalence of severe gastrointestinal complications in male compared to female patients (7/30 versus 1/38, P = 0.009). One male patient died due to catastrophic antiphospholipid syndrome. This study suggests that clinical course in patients with PAPS may be different with significant prevalence of central nervous system involvement in females and gastrointestinal involvement in males. Factors such as accelerated atherosclerosis, hormones, related to gender could be the explanation of these findings.</abstract><cop>Thousand Oaks, CA</cop><pub>SAGE Publications</pub><pmid>16175932</pmid><doi>10.1191/0961203305lu2176oa</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0961-2033
ispartof Lupus, 2005-08, Vol.14 (8), p.607-612
issn 0961-2033
1477-0962
language eng
recordid cdi_proquest_miscellaneous_68610129
source Sage Journals Online
subjects Adult
Antibodies, Anticardiolipin - blood
Anticoagulants
Antiphospholipid Syndrome - blood
Antiphospholipid Syndrome - complications
Cardiovascular Diseases - etiology
Disease
Epidemiology
Female
Females
Follow-Up Studies
Gender
Hospitals
Humans
Kidney Diseases - etiology
Lupus
Male
Males
Middle Aged
Retrospective Studies
Sex Factors
Skin Diseases - etiology
Thrombocytopenia
Thrombocytopenia - etiology
Thrombosis
Womens health
title The impact of gender on clinical manifestations of primary antiphospholipid syndrome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T16%3A47%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20gender%20on%20clinical%20manifestations%20of%20primary%20antiphospholipid%20syndrome&rft.jtitle=Lupus&rft.au=Jara,%20L%20J&rft.date=2005-08&rft.volume=14&rft.issue=8&rft.spage=607&rft.epage=612&rft.pages=607-612&rft.issn=0961-2033&rft.eissn=1477-0962&rft_id=info:doi/10.1191/0961203305lu2176oa&rft_dat=%3Cproquest_cross%3E896410041%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c434t-a31e15eefb51ef0a77b0ed7974f352fb0364efffa23e3d6e32bc8778d51f71e33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=222613824&rft_id=info:pmid/16175932&rft_sage_id=10.1191_0961203305lu2176oa&rfr_iscdi=true